American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non-Small-Cell Lung Cancer.
about
Challenges in Implementing Personalized Medicine for Lung Cancer within a National Healthcare SystemZykadia (Ceritinib) Approved for Patients with Crizotinib-Resistant ALK -Positive Non-Small-Cell Lung Cancer.Expression of LRIG1 is Associated With Good Prognosis for Human Non-small Cell Lung Cancer.Reproducibility of the EGFR immunohistochemistry scores for tumor samples from patients with advanced non-small cell lung cancerTyrosine kinase inhibitors for non-small-cell lung cancer: finding patients who will be responsive.Treatment of elderly patients with stage IV non-small-cell lung cancer.The Victorian Lung Cancer Registry pilot: improving the quality of lung cancer care through the use of a disease quality registry.Emerging roles of RAC1 in treating lung cancer patients.Moving towards molecular-guided treatments: erlotinib and clinical outcomes in non-small-cell lung cancer patients.Prospective analysis on survival outcomes of nonsmall cell lung cancer stages over IIIb treated with HangAm-Dan.Trends and Outcomes of Non-Small-Cell Lung Cancer in Omani Patients: Experience at a university hospital.Timing of chemotherapy-induced neutropenia is a prognostic factor in patients with metastatic non-small-cell lung cancer: a retrospective analysis in gemcitabine-plus-platinum-treated patients.Report of clinical studies on chronochemotherapy for advanced non-small cell lung cancer in China.Improving Access to Cancer Treatments: The Role of Biosimilars.Salvage treatment with erlotinib after gefitinib failure in advanced non-small-cell lung cancer patients with poor performance status: A matched-pair case-control study.In vitro and in vivo antitumor effect of gefitinib nanoparticles on human lung cancer.Cisplatin-based chronotherapy for advanced non-small cell lung cancer patients: a randomized controlled study and its pharmacokinetics analysis.
P2860
Q34608597-86042087-5EF4-4235-9F4A-CBF9BF9A018CQ36333776-6568F6B1-FD24-4855-B5D8-46F036A5A06CQ37328598-330D70FF-714C-4E7C-9978-4707FC212CDAQ37701159-1C90EE27-E97E-4984-A1BA-B011F0DB0A9EQ37894095-347CD331-3F41-4264-B7BE-AAF94FC3AAA7Q37965641-93B3CE2B-F834-4505-88B9-66F7CB7A69E3Q38218370-51B8EB35-E3A6-4705-825F-33131E991145Q38993407-B13227AD-E736-481B-BDAA-8595C4DE3587Q39455567-60989454-D4C6-4C1A-81DE-36E1CFA80CBBQ39816573-7CBF959A-8B9E-428D-8F02-6B21DCCD5185Q42877878-E02D5FF3-257F-4682-A3B7-8375FC096500Q43745548-1D235118-532F-4ADF-A20D-6798BC30756DQ44574723-F49FE41A-0793-406D-B811-2AF1BDA92EAEQ47099597-878CB85F-23D2-4608-A09C-C8962D349236Q50050368-27AAA46A-28A0-4D72-BF60-C1547BBFAF4EQ50272082-9BBFEB4E-DD64-44A1-A299-295A26082346Q52935869-134CC7DF-C6F8-419D-A651-EA5CE790A571
P2860
American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non-Small-Cell Lung Cancer.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
American Society of Clinical O ...... IV Non-Small-Cell Lung Cancer.
@ast
American Society of Clinical O ...... IV Non-Small-Cell Lung Cancer.
@en
American Society of Clinical O ...... IV Non-Small-Cell Lung Cancer.
@nl
type
label
American Society of Clinical O ...... IV Non-Small-Cell Lung Cancer.
@ast
American Society of Clinical O ...... IV Non-Small-Cell Lung Cancer.
@en
American Society of Clinical O ...... IV Non-Small-Cell Lung Cancer.
@nl
prefLabel
American Society of Clinical O ...... IV Non-Small-Cell Lung Cancer.
@ast
American Society of Clinical O ...... IV Non-Small-Cell Lung Cancer.
@en
American Society of Clinical O ...... IV Non-Small-Cell Lung Cancer.
@nl
P2860
P356
P1476
American Society of Clinical O ...... IV Non-Small-Cell Lung Cancer.
@en
P2093
Christopher G Azzoli
Sarah Temin
P2860
P356
10.1200/JOP.091065
P407
P577
2010-01-01T00:00:00Z